provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-11T23:22:02.393352'
end_time: '2026-01-11T23:30:48.070257'
duration_seconds: 525.68
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: NEUROG2
gene_symbol: NEUROG2
uniprot_accession: Q9H2A3
protein_description: 'RecName: Full=Neurogenin-2; Short=NGN-2; AltName: Full=Class
A basic helix-loop-helix protein 8; Short=bHLHa8; AltName: Full=Protein atonal
homolog 4;'
gene_info: Name=NEUROG2; Synonyms=ATOH4, BHLHA8, NGN2;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359);
HLH_DNA-bd_sf. (IPR036638); Ngn-2_bHLH. (IPR032655); HLH (PF00010)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 22

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

• UniProt Accession: Q9H2A3
• Protein Description: RecName: Full=Neurogenin-2; Short=NGN-2; AltName: Full=Class A basic helix-loop-helix protein 8; Short=bHLHa8; AltName: Full=Protein atonal homolog 4;
• Gene Information: Name=NEUROG2; Synonyms=ATOH4, BHLHA8, NGN2;
• Organism (full): Homo sapiens (Human).
• Protein Family: Not specified in UniProt
• Key Domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); Ngn-2_bHLH. (IPR032655); HLH (PF00010)

MANDATORY VERIFICATION STEPS:

1. Check if the gene symbol "NEUROG2" matches the protein description above
2. Verify the organism is correct: Homo sapiens (Human).
3. Check if protein family/domains align with what you find in literature
4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'NEUROG2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene NEUROG2 (gene ID: NEUROG2, UniProt: Q9H2A3) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

• UniProt Accession: Q9H2A3
• Protein Description: RecName: Full=Neurogenin-2; Short=NGN-2; AltName: Full=Class A basic helix-loop-helix protein 8; Short=bHLHa8; AltName: Full=Protein atonal homolog 4;
• Gene Information: Name=NEUROG2; Synonyms=ATOH4, BHLHA8, NGN2;
• Organism (full): Homo sapiens (Human).
• Protein Family: Not specified in UniProt
• Key Domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); Ngn-2_bHLH. (IPR032655); HLH (PF00010)

MANDATORY VERIFICATION STEPS:

1. Check if the gene symbol "NEUROG2" matches the protein description above
2. Verify the organism is correct: Homo sapiens (Human).
3. Check if protein family/domains align with what you find in literature
4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'NEUROG2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene NEUROG2 (gene ID: NEUROG2, UniProt: Q9H2A3) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity/domain verification: The target is Homo sapiens NEUROG2 (neurogenin‑2), a proneural basic helix‑loop‑helix (bHLH) transcription factor. Recent studies consistently describe NEUROG2 as a bHLH TF that binds E‑box motifs and drives cortical neurogenesis; motif preferences and dimerization characteristics are discussed below. Organism- and symbol-level ambiguity was not encountered in the cited human-focused works, which explicitly analyze NEUROG2/NGN2 in human organoids and human cells (Q9H2A3 context) or use cross-species models to infer conserved functions (mouse ES/NPC lines, cortical tissue) (chinchalongporn2024neurog2regulatesa pages 4-6, manelli2024contextdependentepigenomerewiring pages 1-3).

Comprehensive research report

1) Key concepts and definitions
- Molecular identity: NEUROG2 is a proneural bHLH transcription factor that activates neuronal differentiation programs in the developing cortex and related neural contexts. It is widely recognized as the predominant neurogenin in corticogenesis and a central regulator of neurogenic fate (chinchalongporn2024neurog2regulatesa pages 4-6, manelli2024contextdependentepigenomerewiring pages 1-3).
- DNA recognition and motif preferences: NEUROG2 binds E‑box (CANNTG) motifs. Human fibroblast reprogramming data report a preference toward “CAT” E‑box variants for NGN2 relative to ASCL1’s “CAG” preference, corresponding to differential target selection during early conversion (Nov 2024) (samoilova2024asnapshotof pages 9-11). Context-dependent binding of NEUROG2, with direct activation of canonical targets Dll1/Dll3, Rnd2, Neurod1/2, and Lhx2, has been demonstrated, consistent with E‑box targeting modulated by cell state (Oct 2024) (manelli2024contextdependentepigenomerewiring pages 1-3).
- Dimerization and co-factors: NEUROG2 acts as a bHLH dimer; context-dependent cooperation with other TFs and chromatin regulators is prominent. Direct evidence in the included papers emphasizes co-regulation of downstream bHLH cascades (e.g., NEUROD1/2), and signaling/cis-regulatory modules that tune NEUROG2 function (manelli2024contextdependentepigenomerewiring pages 1-3). Specific E-protein/ID-protein interactions are classical for bHLH factors but not directly quantified in the 2023–2024 human-focused sources cited here.
- Subcellular localization: As a transcription factor, NEUROG2 functions in the nucleus to regulate gene expression. While nuclear localization is expected for bHLH TFs, the included 2023–2024 sources focus on function and targets rather than direct localization assays; this point is an inference consistent with function (manelli2024contextdependentepigenomerewiring pages 1-3, chinchalongporn2024neurog2regulatesa pages 4-6).

2) Recent developments and latest research (prioritizing 2023–2024)
- Human/primate cortical programs: A Jan 2024 human organoid and fetal cortex study shows NEUROG2 enrichment in human cortical progenitors, especially intermediate progenitors (IPCs), and identifies a human-specific NEUROG2 program including PPP1R17 and extracellular matrix (ECM) genes that may modulate progenitor dynamics; NEUROG2-mCherry–high human organoid cells upregulated ECM signatures and linked to OPC-like expression. A phospho-dead Neurog2 variant more strongly induced canonical proneural targets (Dll3, Rnd2, Neurod1) in gain-of-function assays (bioRxiv, Jan 11, 2024; doi:10.1101/2024.01.11.575174) (chinchalongporn2024neurog2regulatesa pages 4-6, chinchalongporn2024neurog2regulatesa pages 31-32).
- Context-dependent epigenome targeting: A 2024 mouse ES-to-NPC system with inducible Neurog2 reports thousands of differentially expressed genes and extensive, context-dependent Neurog2 binding (ES-specific, NPC-specific, and shared peaks), with binding associated with increased chromatin accessibility and direct activation of proneural targets including Dll1, Rnd2, Lhx2, Neurod1/2 (bioRxiv, Oct 18, 2024; doi:10.1101/2024.10.18.618996) (manelli2024contextdependentepigenomerewiring pages 1-3).
- LHX2–NEUROG2 axis in corticogenesis: Loss of Lhx2 in progenitors causes a “massive” increase of Neurog2 and dendritic/spine defects in layer II/III neurons; shRNA knockdown of Neurog2 in this context completely rescued apical dendrite defects and partially rescued basal dendrite defects, indicating LHX2 suppresses Neurog2 in progenitors to tune neuronal morphogenesis (bioRxiv, Jan 30, 2024; doi:10.1101/2024.01.30.577728) (bose2024lhx2regulatesdendritic pages 15-20).
- Post-translational tuning and pioneer-like activity: Human iPSC cortical organoid work shows phosphorylation of NEUROG2 at T149 acts as a rheostat between pioneer-like chromatin remodeling and transactivation; a T149A mutant increased neurogenesis and premature chromatin opening enriched for AP‑1 motifs, while AP‑1 inhibition partially rescued the phenotype, supporting a cooperative module between NEUROG2 chromatin activity and AP‑1 (bioRxiv, Nov 2025; doi:10.1101/2025.10.27.684791) (pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13, pigeon2025posttranslationaltuningof pages 37-38). Although 2025, this builds directly on 2023–2024 insights that NEUROG2’s phosphorylation state modulates activity (chinchalongporn2024neurog2regulatesa pages 31-32).
- Disease/oncogenic setting (2024): NEUROG2 emerged as a synthetic vulnerability in MYCN‑overexpressing neuroendocrine prostate cancer (NEPC). NEUROG2 knockdown selectively reduced colony formation and viability in MYCN+ lines, suppressed neuroendocrine differentiation marker expression (SYP, CHGA, NSE), and significantly reduced orthotopic NEPC tumor growth in vivo (preprints: Nov 2024 and Aug 19, 2024) (vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27).

3) Primary molecular function, pathways, and cellular context
- Molecular role: NEUROG2 is a sequence-specific bHLH transcription factor that initiates and propagates neurogenic gene expression programs. Direct targets and effector cascades include Delta/Notch pathway components (Dll1/Dll3), actin/cytoskeleton and migration factors (Rnd2), and downstream neuronal bHLH factors (Neurod1/2), consistent with inducing neuronal differentiation and neurite outgrowth programs (manelli2024contextdependentepigenomerewiring pages 1-3, chinchalongporn2024neurog2regulatesa pages 31-32).
- Cellular and developmental context in human systems: In human fetal cortex datasets and human cerebral organoids, NEUROG2 is broadly expressed in neural progenitors, particularly IPCs, and is scarce in postmitotic neurons, indicating a progenitor-focused role in fate commitment and program initiation. Reported percentages: 72.06% of neural progenitor cells (NPCs) expressed NEUROG2; 38.62% co-expressed NEUROG1 and 33.4% were NEUROG2-only (chinchalongporn2024neurog2regulatesa pages 4-6).
- Cross-regulatory interactions: LHX2 suppresses Neurog2 in progenitors; reducing NEUROG2 can rescue Lhx2-deficient dendritic arborization defects, indicating a developmental pathway where LHX2 tempers NEUROG2 to properly orchestrate dendrite morphogenesis and spine maturation. In postmitotic neurons, LHX2 impacts Wnt/β‑catenin signaling independently, underscoring stage-specific pathway crosstalk (bose2024lhx2regulatesdendritic pages 15-20).
- Chromatin and pioneer-like activity: NEUROG2 displays context-dependent genomic occupancy and can associate with chromatin opening. In human cortical progenitors, phosphorylation at T149 modulates a pioneer-like mode that increases chromatin accessibility with enrichment for AP‑1 (JUN/FOS) motifs; inhibition of AP‑1 activity partially reverses premature neurogenesis, demonstrating cooperation with AP‑1 in NEUROG2-driven chromatin remodeling (pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13).

4) Post-transcriptional/post-translational regulation
- Phospho-regulation: Human/primate-focused work indicates proline-directed SP/TP phosphorylation can constrain NEUROG2 transactivation, while phospho-dead variants enhance activation of classical targets and can reprogram target selection. The T149 site in the bHLH region is a key regulatory node; T149A increases neurogenesis and chromatin opening yet can reduce classical transactivation in reporter assays, evidencing functional uncoupling between chromatin remodeling and transactivation (chinchalongporn2024neurog2regulatesa pages 31-32, pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13).

5) Human/primate-specific programs and evolutionary considerations
- Human-specific regulatory outputs: In human organoids, NEUROG2-mCherry–high cells showed increased ECM gene expression and PPP1R17 induction, which is associated with human-accelerated regulatory regions. These outputs were not equivalently enriched in mouse Neurog2:mCherry cortical cells, suggesting human-biased NEUROG2 circuitry that may influence basal progenitor expansion and developmental tempo (bioRxiv, Jan 2024) (chinchalongporn2024neurog2regulatesa pages 31-32, chinchalongporn2024neurog2regulatesa pages 4-6).

6) Direct neuronal reprogramming and implementations
- Human fibroblast reprogramming: Single-factor NGN2 (NEUROG2) ectopic expression in human LF1 fibroblasts produced the strongest pro-neural transcriptional reconfiguration among tested factors at day 5, with increased nestin and β‑III‑tubulin protein levels and activation of neuronal ion channel and synaptic programs. TF activity analysis confirmed robust NEUROG2 activity; pathway analyses suggested concurrent induction of neural stem/progenitor and neuronal lineage signatures (IJMS, Nov 2024; doi:10.3390/ijms252212385) (samoilova2024asnapshotof pages 3-7, samoilova2024asnapshotof pages 9-11). While detailed conversion efficiencies were not provided in the excerpt, early marker kinetics support NEUROG2’s potency in initiating neural programs in human cells.
- Chromatin context in reprogramming: Broader proneural literature places NEUROG2 as a potent driver whose activity can be enhanced or shifted by chromatin modifiers and co-factors. The included 2024–2025 sources support a model where NEUROG2’s chromatin engagement and pioneer-like features are tunable via phosphorylation and cooperating TFs (e.g., AP‑1), with implications for optimizing reprogramming cocktails (pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13, manelli2024contextdependentepigenomerewiring pages 1-3).

7) Disease associations and oncogenic contexts
- Neuroendocrine prostate cancer (NEPC): NEUROG2 is upregulated in NEPC compared to CRPC and becomes selectively essential in MYCN-overexpressing contexts. Knockdown reduced colony formation more strongly in MYCN+ 22‑MYC cells than in 22Rv1, suppressed viability in N‑Myc+/myrAKT1+ LASCPC‑01 cells, and downregulated neuroendocrine markers SYP, CHGA, NSE. Correlations in NEPC cohorts: NEUROG2 vs SYP r = 0.72 (p = 0.003), vs INSM1 r = 0.79 (p = 0.0006). In orthotopic mouse models, NEUROG2 silencing significantly suppressed NEPC tumor growth (Research Square, Nov 2024; bioRxiv, Aug 19, 2024) (vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27).

8) Relevant statistics and quantitative outcomes (selected)
- Human organoids/fetal cortex: 72.06% of NPCs expressed NEUROG2; 38.62% co-expressed NEUROG1, 33.4% NEUROG2-only. mCherry‑high human organoid cells: neuronal markers Stmn2 log2FC 4.65; Gap43 log2FC 2.41 (chinchalongporn2024neurog2regulatesa pages 4-6, chinchalongporn2024neurog2regulatesa pages 31-32).
- Context-dependent ES/NPC binding: Neurog2 ChIP‑seq peaks: 1,946 ES-specific, 2,537 NPC-specific, 15,199 shared; DEGs: 3,707 (ES), 3,072 (NPC); 557 commonly upregulated genes including Dll1/Rnd2/Lhx2/Neurod1/2 (manelli2024contextdependentepigenomerewiring pages 1-3).
- Phosphorylation effects: In human cortical organoids, T149A (“TA/TA”) increased DCX+ cells by ~4-fold relative to WT; AP‑1 inhibitor (SR11302) reduced DCX+ cells by ~1.8‑fold and partially rescued premature neurogenesis. Large-scale quantification encompassed ~400 tracked RGCs and ~100 million cells across ~200 organoids (pigeon2025posttranslationaltuningof pages 11-13, pigeon2025posttranslationaltuningof pages 37-38).
- NEPC oncogenic context: Strong correlation between NEUROG2 and NE markers in NEPC but not CRPC (e.g., SYP r = 0.72, p = 0.003 in NEPC); selective loss of colony formation/viability upon NEUROG2 knockdown in MYCN+ lines; significant suppression of orthotopic tumor growth upon NEUROG2 silencing (vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27).

Expert opinions and analysis
- The convergence of human organoid data and chromatin-binding studies suggests NEUROG2’s function depends on both its phosphorylation state and available co-factors, producing distinct outputs across progenitor states. The human-specific association with PPP1R17 and ECM programs posits a role for NEUROG2 in tuning cortical progenitor niche properties unique to primates (chinchalongporn2024neurog2regulatesa pages 31-32, chinchalongporn2024neurog2regulatesa pages 4-6). The LHX2–NEUROG2 balance underscores that precise repression of NEUROG2 in progenitors is required for appropriate dendrite morphogenesis, situating NEUROG2 within a stage-specific, modular regulatory network (bose2024lhx2regulatesdendritic pages 15-20). Finally, the NEPC data indicate that adult oncogenic contexts can co‑opt a NEUROG2-driven neuroendocrine gene network, and that targeting NEUROG2 might be therapeutically beneficial in MYCN‑driven NEPC while sparing non-malignant tissues with minimal NEUROG2 expression (vizeacoumar2024anovelrole pages 10-13).

Current applications and implementations
- Forward programming and disease modeling: NGN2 is widely used to rapidly generate induced neurons from human cells; the 2024 RNA‑seq study confirms potent early activation of neuronal programs and markers, informing protocol timing and companion factors (samoilova2024asnapshotof pages 3-7, samoilova2024asnapshotof pages 9-11). In developmental modeling, NEUROG2‑tagged human organoids enable lineage tracing and discovery of human‑specific targets pertinent to cortical expansion and timing (chinchalongporn2024neurog2regulatesa pages 31-32, chinchalongporn2024neurog2regulatesa pages 4-6).
- Oncology: Functional genomics and in vivo models point to NEUROG2 as a targetable dependency in MYCN‑overexpressing NEPC; translational development would need to balance on‑target effects in neuroendocrine tissues versus low expression in non-malignant prostate (vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27).

Limitations and gaps
- Subcellular localization and detailed E‑protein/ID‑protein interaction data were not directly quantified in the included 2023–2024 human-centered excerpts; statements are inferred from function and general bHLH biology.
- Some mechanistic work (e.g., AP‑1 cooperation and T149 rheostat) is from late‑2025 preprints but is complementary to 2024 phosphorylation findings and is included here for completeness with clear dating (pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13, pigeon2025posttranslationaltuningof pages 37-38, chinchalongporn2024neurog2regulatesa pages 31-32).

Key artifact summarizing recent evidence
| Area / Theme | Key finding | Model / system | Quantitative / statistical outcomes | URL / DOI | Publication date | Citation ID |
|---|---|---|---:|---|---|---|
| Human organoids & fetal cortex (NEUROG2 expression & targets) | NEUROG2 enriched in cortical progenitors/IPCs; human-specific targets include PPP1R17 and ECM genes; phospho-dead Neurog2SA9TA1 shows stronger induction of neurogenic targets | NEUROG2-mCherry knock-in hESC cerebral organoids; human fetal scRNA-seq | 72.06% of NPCs express NEUROG2 (38.62% co-express NEUROG1; 33.4% NEUROG2-only); Stmn2 log2FC = 4.65; Gap43 log2FC = 2.41; phospho-dead mutant = "significantly better" induction of Dll3/Rnd2/Neurod1 (qual.) | https://doi.org/10.1101/2024.01.11.575174 | 2024-01-11 | (chinchalongporn2024neurog2regulatesa pages 4-6, chinchalongporn2024neurog2regulatesa pages 31-32) |
| Context-dependent binding & chromatin accessibility | NEUROG2 exhibits context-dependent binding and activates neurogenic targets (Dll1, Rnd2, Lhx2, Neurod1/2); binding correlates with chromatin opening | Flag-Neurog2 doxycycline-inducible Tet-ON ES line (mouse); ChIP-seq, RNA-seq, ATAC | DEGs: 3707 (ES), 3072 (NPC); 557 commonly upregulated genes; ChIP-seq peaks: 1,946 ES-specific, 2,537 NPC-specific, 15,199 shared peaks | https://doi.org/10.1101/2024.10.18.618996 | 2024-10 (preprint) | (manelli2024contextdependentepigenomerewiring pages 1-3) |
| Post-translational regulation — T149 phosphorylation (tuning pioneer-like activity) | Phosphorylation at T149 modulates NEUROG2's pioneer-like chromatin activity vs transactivation: phospho-dead increases chromatin opening and neurogenesis but can reduce transactivation in reporters | Human iPSC cortical organoids and CRISPR NEUROG2 T149A/KO lines; lineage tracing, snRNA-seq/ATAC | TA/TA (T149A) RGCs show ~4-fold higher DCX expression; tracked ~400 RGCs; organoid quantification across ~200 hCOs (~100 million cells); AP-1 inhibitor SR11302 reduced DCX+ cells by ~1.8-fold (partial rescue) | https://doi.org/10.1101/2025.10.27.684791 | 2025-11 (preprint) | (pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13, pigeon2025posttranslationaltuningof pages 37-38) |
| LHX2 → NEUROG2 axis in corticogenesis | LHX2 represses Neurog2 in progenitors; loss of Lhx2 causes large Neurog2 upregulation and dendritic/morphology defects that are partially/completely rescued by Neurog2 knockdown | Mouse neocortex; Lhx2 conditional mutants (progenitor and postmitotic perturbations); in vivo/in vitro neuronal analyses | Loss of Lhx2 → "massive" Neurog2 increase; Neurog2 knockdown: complete rescue of apical dendrite defects and partial rescue of basal dendrites (statistical tests reported; rescue significant) | https://doi.org/10.1101/2024.01.30.577728 | 2024-01-30 | (bose2024lhx2regulatesdendritic pages 15-20) |
| Oncogenic / disease context — NEPC (MYCN-driven) | NEUROG2 is selectively required for survival and neuroendocrine plasticity of MYCN-overexpressing prostate cancer cells; knockdown reduces colony formation, viability, NED markers, and orthotopic tumor growth | Human prostate cancer cell lines (22-MYC, 22Rv1, LASCPC-01); orthotopic NEPC mouse models; shRNA/CRISPR knockdown | NEPC correlations: NEUROG2 vs SYP r = 0.72, p = 0.003; NEUROG2 knockdown reduced colony formation preferentially in 22-MYC vs 22Rv1; orthotopic tumor growth significantly suppressed by NEUROG2 silencing | https://doi.org/10.21203/rs.3.rs-5313977/v1 ; https://doi.org/10.1101/2024.08.16.607954 | 2024 (preprints); Aug 19, 2024 (Walke bioRxiv) | (vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27) |

Table: Compact table summarizing 2024–2025 experimental evidence on human NEUROG2 (Q9H2A3), including expression, targets, chromatin activity, phosphorylation effects, developmental interactions, and oncogenic roles, with DOIs and context citations for each finding.

References with URLs and dates
- Chinchalongporn V et al. NEUROG2 regulates a human-specific neurodevelopmental gene regulatory program. bioRxiv. Posted 2024-01-11. doi:10.1101/2024.01.11.575174. https://doi.org/10.1101/2024.01.11.575174 (chinchalongporn2024neurog2regulatesa pages 31-32, chinchalongporn2024neurog2regulatesa pages 4-6)
- Manelli V et al. Context-dependent epigenome rewiring during neuronal differentiation. bioRxiv. Posted 2024-10-18. doi:10.1101/2024.10.18.618996. https://doi.org/10.1101/2024.10.18.618996 (manelli2024contextdependentepigenomerewiring pages 1-3)
- Bose M et al. LHX2 regulates dendritic morphogenesis… via Neurog2 suppression in progenitors. bioRxiv. Posted 2024-01-30. doi:10.1101/2024.01.30.577728. https://doi.org/10.1101/2024.01.30.577728 (bose2024lhx2regulatesdendritic pages 15-20)
- Pigeon J et al. Post-translational Tuning of Human Cortical Progenitor Neuronal Output. bioRxiv. Posted 2025-11-03. doi:10.1101/2025.10.27.684791. https://doi.org/10.1101/2025.10.27.684791 (pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13, pigeon2025posttranslationaltuningof pages 37-38)
- Vizeacoumar F et al. A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer. Research Square preprint. Posted 2024-11. doi:10.21203/rs.3.rs-5313977/v1. https://doi.org/10.21203/rs.3.rs-5313977/v1 (vizeacoumar2024anovelrole pages 10-13)
- Walke P et al. A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer. bioRxiv. Posted 2024-08-19. doi:10.1101/2024.08.16.607954. https://doi.org/10.1101/2024.08.16.607954 (walke2025anovelrole pages 20-27)
- Samoilova EM et al. A Snapshot of Early Transcriptional Changes… NGN2 in human fibroblasts. Int J Mol Sci. Published 2024-11-21. doi:10.3390/ijms252212385. https://doi.org/10.3390/ijms252212385 (samoilova2024asnapshotof pages 9-11, samoilova2024asnapshotof pages 3-7)

Citations by section
- Key concepts/definitions and motif preference: (samoilova2024asnapshotof pages 9-11, manelli2024contextdependentepigenomerewiring pages 1-3, chinchalongporn2024neurog2regulatesa pages 4-6)
- Recent developments: human/primate programs (chinchalongporn2024neurog2regulatesa pages 31-32, chinchalongporn2024neurog2regulatesa pages 4-6); context-dependent binding (manelli2024contextdependentepigenomerewiring pages 1-3); LHX2–NEUROG2 axis (bose2024lhx2regulatesdendritic pages 15-20); phospho/pioneer-like activity (pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13); NEPC (vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27)
- Molecular function and pathways: (manelli2024contextdependentepigenomerewiring pages 1-3, chinchalongporn2024neurog2regulatesa pages 31-32, chinchalongporn2024neurog2regulatesa pages 4-6, bose2024lhx2regulatesdendritic pages 15-20)
- Post-translational regulation: (chinchalongporn2024neurog2regulatesa pages 31-32, pigeon2025posttranslationaltuningof pages 1-3, pigeon2025posttranslationaltuningof pages 11-13)
- Human/primate-specific programs: (chinchalongporn2024neurog2regulatesa pages 31-32, chinchalongporn2024neurog2regulatesa pages 4-6)
- Reprogramming and applications: (samoilova2024asnapshotof pages 3-7, samoilova2024asnapshotof pages 9-11)
- Disease associations: (vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27)
- Quantitative/statistical outcomes: (chinchalongporn2024neurog2regulatesa pages 4-6, chinchalongporn2024neurog2regulatesa pages 31-32, manelli2024contextdependentepigenomerewiring pages 1-3, pigeon2025posttranslationaltuningof pages 11-13, pigeon2025posttranslationaltuningof pages 37-38, vizeacoumar2024anovelrole pages 10-13, walke2025anovelrole pages 20-27)

References

1. (chinchalongporn2024neurog2regulatesa pages 4-6): Vorapin Chinchalongporn, Lakshmy Vasan, Fermisk Saleh, Dawn Zinyk, Hussein Ghazale, Ana-Maria Oproescu, Shruti Patel, Matthew Rozak, Yutaka Amemiya, Sisu Han, Alexandra Moffat, Sandra E Black, JoAnne McLaurin, Jamie Near, Arun Seth, Maged Goubran, Orly Reiner, Satoshi Okawa, and Carol Schuurmans. Neurog2 regulates a human-specific neurodevelopmental gene regulatory program. bioRxiv, Jan 2024. URL: https://doi.org/10.1101/2024.01.11.575174, doi:10.1101/2024.01.11.575174. This article has 2 citations and is from a poor quality or predatory journal.

2. (manelli2024contextdependentepigenomerewiring pages 1-3): Vera Manelli, Jeisimhan Diwakar, Sude Beşkardeş, Dácil Alonso-Gil, Ignasi Forné, Faye Chong, Axel Imhof, and Boyan Bonev. Context-dependent epigenome rewiring during neuronal differentiation. bioRxiv, Oct 2024. URL: https://doi.org/10.1101/2024.10.18.618996, doi:10.1101/2024.10.18.618996. This article has 1 citations and is from a poor quality or predatory journal.

3. (samoilova2024asnapshotof pages 9-11): Ekaterina M. Samoilova, Daria A. Chudakova, Erdem B. Dashinimaev, Anastasiya V. Snezhkina, Olga M. Kudryashova, Anastasia V. Lipatova, Alesya V. Soboleva, Pavel O. Vorob’yev, Vladimir T. Valuev-Elliston, Natalia F. Zakirova, Alexander V. Ivanov, and Vladimir P. Baklaushev. A snapshot of early transcriptional changes accompanying the pro-neural phenotype switch by ngn2, ascl1, sox2, and msi1 in human fibroblasts: an rna-seq study. International Journal of Molecular Sciences, 25:12385, Nov 2024. URL: https://doi.org/10.3390/ijms252212385, doi:10.3390/ijms252212385. This article has 0 citations and is from a poor quality or predatory journal.

4. (chinchalongporn2024neurog2regulatesa pages 31-32): Vorapin Chinchalongporn, Lakshmy Vasan, Fermisk Saleh, Dawn Zinyk, Hussein Ghazale, Ana-Maria Oproescu, Shruti Patel, Matthew Rozak, Yutaka Amemiya, Sisu Han, Alexandra Moffat, Sandra E Black, JoAnne McLaurin, Jamie Near, Arun Seth, Maged Goubran, Orly Reiner, Satoshi Okawa, and Carol Schuurmans. Neurog2 regulates a human-specific neurodevelopmental gene regulatory program. bioRxiv, Jan 2024. URL: https://doi.org/10.1101/2024.01.11.575174, doi:10.1101/2024.01.11.575174. This article has 2 citations and is from a poor quality or predatory journal.

5. (bose2024lhx2regulatesdendritic pages 15-20): Mahima Bose, Sreenath Ravindran, Sanjna Kumari, Achintya Srivastava, Archana Iyer, Binita Vedak, Ishita Talwar, Rishikesh Narayanan, and Shubha Tole. Lhx2 regulates dendritic morphogenesis in layer ii/iii of the neocortex via distinct pathways in progenitors and postmitotic neurons. bioRxiv, Jun 2024. URL: https://doi.org/10.1101/2024.01.30.577728, doi:10.1101/2024.01.30.577728. This article has 1 citations and is from a poor quality or predatory journal.

6. (pigeon2025posttranslationaltuningof pages 1-3): Julien Pigeon, Tamina Dietl, Myriame Abou Mrad, Ludovico Rizzuti, Miguel V. Silva, Natasha Danda, Corentine Marie, Clarisse Brunet Avalos, Hayat Mokrani, Laila El Khattabi, Alexandre D. Baffet, Diogo S. Castro, Carlos Parras, Boyan Bonev, and Bassem A. Hassan. Post-translational tuning of human cortical progenitor neuronal output. bioRxiv, Nov 2025. URL: https://doi.org/10.1101/2025.10.27.684791, doi:10.1101/2025.10.27.684791. This article has 1 citations and is from a poor quality or predatory journal.

7. (pigeon2025posttranslationaltuningof pages 11-13): Julien Pigeon, Tamina Dietl, Myriame Abou Mrad, Ludovico Rizzuti, Miguel V. Silva, Natasha Danda, Corentine Marie, Clarisse Brunet Avalos, Hayat Mokrani, Laila El Khattabi, Alexandre D. Baffet, Diogo S. Castro, Carlos Parras, Boyan Bonev, and Bassem A. Hassan. Post-translational tuning of human cortical progenitor neuronal output. bioRxiv, Nov 2025. URL: https://doi.org/10.1101/2025.10.27.684791, doi:10.1101/2025.10.27.684791. This article has 1 citations and is from a poor quality or predatory journal.

8. (pigeon2025posttranslationaltuningof pages 37-38): Julien Pigeon, Tamina Dietl, Myriame Abou Mrad, Ludovico Rizzuti, Miguel V. Silva, Natasha Danda, Corentine Marie, Clarisse Brunet Avalos, Hayat Mokrani, Laila El Khattabi, Alexandre D. Baffet, Diogo S. Castro, Carlos Parras, Boyan Bonev, and Bassem A. Hassan. Post-translational tuning of human cortical progenitor neuronal output. bioRxiv, Nov 2025. URL: https://doi.org/10.1101/2025.10.27.684791, doi:10.1101/2025.10.27.684791. This article has 1 citations and is from a poor quality or predatory journal.

9. (vizeacoumar2024anovelrole pages 10-13): Franco Vizeacoumar, Prachi Walke, Jared Price, Frederick Vizeacoumar, Nickson Joseph, Vincent Maranda, Bari Chowdhury, Jay Patel, Yue Zhang, He Dong, Lara New, Ashtalakshmi Ganapathysamy, Li Hui Gong, Hussain Elhasasna, Kalpana Bhanumathy, Yuliang Wu, Andrew Freywald, and Anand Krishnan. A novel role for neurog2 in mycn driven neuroendocrine plasticity of prostate cancer. Nov 2024. URL: https://doi.org/10.21203/rs.3.rs-5313977/v1, doi:10.21203/rs.3.rs-5313977/v1.

10. (walke2025anovelrole pages 20-27): Prachi Walke, Jared D.W. Price, Frederick S. Vizeacoumar, Nickson Joseph, Vincent Maranda, Bari Chowdhury, Jay Patel, Yue Zhang, He Dong, Lara New, Ashtalakshmi Ganapathysamy, Li Hui Gong, Hussain Elhasasna, Kalpana K. Bhanumathy, Yuliang Wu, Andrew Freywald, Anand Krishnan, and Franco J. Vizeacoumar. A novel role for neurog2 in mycn driven neuroendocrine plasticity of prostate cancer. Oncogene, 44:2460-2473, Aug 2025. URL: https://doi.org/10.1101/2024.08.16.607954, doi:10.1101/2024.08.16.607954. This article has 2 citations and is from a domain leading peer-reviewed journal.

11. (samoilova2024asnapshotof pages 3-7): Ekaterina M. Samoilova, Daria A. Chudakova, Erdem B. Dashinimaev, Anastasiya V. Snezhkina, Olga M. Kudryashova, Anastasia V. Lipatova, Alesya V. Soboleva, Pavel O. Vorob’yev, Vladimir T. Valuev-Elliston, Natalia F. Zakirova, Alexander V. Ivanov, and Vladimir P. Baklaushev. A snapshot of early transcriptional changes accompanying the pro-neural phenotype switch by ngn2, ascl1, sox2, and msi1 in human fibroblasts: an rna-seq study. International Journal of Molecular Sciences, 25:12385, Nov 2024. URL: https://doi.org/10.3390/ijms252212385, doi:10.3390/ijms252212385. This article has 0 citations and is from a poor quality or predatory journal.

Citations

1. samoilova2024asnapshotof pages 9-11
2. manelli2024contextdependentepigenomerewiring pages 1-3
3. vizeacoumar2024anovelrole pages 10-13
4. walke2025anovelrole pages 20-27
5. pigeon2025posttranslationaltuningof pages 1-3
6. pigeon2025posttranslationaltuningof pages 11-13
7. pigeon2025posttranslationaltuningof pages 37-38
8. samoilova2024asnapshotof pages 3-7
9. https://doi.org/10.1101/2024.01.11.575174
10. https://doi.org/10.1101/2024.10.18.618996
11. https://doi.org/10.1101/2025.10.27.684791
12. https://doi.org/10.1101/2024.01.30.577728
13. https://doi.org/10.21203/rs.3.rs-5313977/v1
14. https://doi.org/10.1101/2024.08.16.607954
15. https://doi.org/10.3390/ijms252212385
16. https://doi.org/10.1101/2024.01.11.575174,
17. https://doi.org/10.1101/2024.10.18.618996,
18. https://doi.org/10.3390/ijms252212385,
19. https://doi.org/10.1101/2024.01.30.577728,
20. https://doi.org/10.1101/2025.10.27.684791,
21. https://doi.org/10.21203/rs.3.rs-5313977/v1,
22. https://doi.org/10.1101/2024.08.16.607954,